Sulzer Medica launches heart valve outside US:
This article was originally published in Clinica
Sulzer Medica is to launch its Carbomedics prosthetic mitral heart valve, SuMit, in western Europe, Canada and Japan after the successful outcome of clinical programmes. The Swiss company's cardiac surgery company, Sulzer Carbomedics began a controlled-release clinical programme in the UK, Denmark, France, Germany and Canada after attaching the CE mark in 1998. The valve can be used in ventricular hypertrophy, repeat mitral valve replacements, double valve procedures and surgery on small left ventricles. The mechanical heart valve market, excluding the US, is valued at around $254 million.
You may also be interested in...
Target guests in selected locations will be able to shop a curated Ulta Beauty section in the second half of 2021. The partnership could attract new clientele to Target stores and give Ulta a boost following nationwide store closures this year due to COVID.
COVID-19 Vaccines: ACIP’s Allocation Proposal Prioritizes Long-Term Care Residents, Essential Workers
First group to receive vaccine would comprise health care personnel and residents of long-term care facilities; next in line are non-health care essential workers, who would take priority over adults with high-risk medical conditions and those ages 65 years and older, according to the CDC advisory committee’s proposed allocation framework.
Azar says ACIP’s prioritization recommendations should carry weight, but states will be final arbiter of who is vaccinated.